|
Recently Approved Documents
H44-A2, Reticulocyte Counting by Flow Cytometry; M33-A, Antiviral Susceptibility Testing; and M36-A, Toxoplasma gondii
NCCLS is pleased to announce that the following documents have been approved by the Board of Directors for publication. See the text following this list for information on options for member and nonmember organizations to obtain copies.
-Second Notice-
H44-A2 — Methods for Reticulocyte Counting (Automated Blood Cell Counters, Flow Cytometry, and Supravital Dyes); Approved Guideline—Second Edition
This document provides guidance for the performance of reticulocyte counting by flow cytometry. It includes methods for determining the trueness and precision of the reticu-locyte flow cytometry instrument and a recommended reference procedure.
M33-A — Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard
This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.
M36-A — Clinical Use and Interpretation of Serologic Tests for Toxoplasma gondii; Approved Guideline
This document is intended to serve as a guide to aid in the interpretation of tests for the diagnosis of Toxoplasma infection.
The NCCLS procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community which participates in the consensus process by carefully reviewing and commenting on the standard or guideline. The listed approved consensus documents are available for purchase. You may automatically receive or select approved-level documents as a member benefit. For information on joining NCCLS, and viewing membership options and benefits, click here.
[
return to top ]
|
